Misdiagnosed gastrinoma: A case report
- Authors:
- Qi‑Kai Sun
- Wei Wang
- Hang‑Cheng Zhou
- Yang Lv
- Ji‑Hai Yu
- Jin‑Liang Ma
- Wei‑Dong Jia
- Ge‑Liang Xu
View Affiliations
Affiliations: Department of General Surgery, Anhui Provincial Hospital, Anhui Medical University, Hefei, Anhui 230001, P.R. China, Department of Medical Oncology, Anhui Provincial Hospital, Anhui Medical University, Hefei, Anhui 230001, P.R. China, Department of Pathology, Anhui Provincial Hospital, Anhui Medical University, Hefei, Anhui 230001, P.R. China
- Published online on: April 1, 2014 https://doi.org/10.3892/ol.2014.2019
-
Pages:
2089-2092
Metrics: Total
Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
This article is mentioned in:
Abstract
Gastrinoma is most commonly located in the gastrinoma triangle (comprising of the duodenum, pancreas and bile ducts) or in the adjacent lymph nodes. Due to the low mortality rate, it is often misdiagnosed as other diseases with similar clinical characteristics, such as a solid pseudopapillary tumor of the pancreas (SPTP). Therefore, the current study reports a rare case of gastrinoma located in the tail of the pancreas of a female patient under medical examination, who exhibited no clinical symptoms. The tumor, which was located in the body and tail of the pancreas, was successfully resected and the spleen was preserved. The outcome of surgery combined with the postoperative pathological examination resulted in the patient being misdiagnosed with a SPTP. During the consequent six‑year follow‑up period, low‑density liver lesions and an intractable peptic ulcer gradually appeared. Finally, the patient diagnosis was confirmed as a malignant pancreatic neuroendocrine carcinoma with liver metastases. On June 1, 2011, a liver transplant was successfully performed and the patient has maintained a good overall condition. The underlying clinical and pathological factors that may have resulted in misdiagnosis are investigated in the present study. Through providing our preliminary clinical experiences and lessons, the aim of the present study was to focus the attention of clinicians on this type of cancer in order to improve its diagnosis and treatment.
View References
|
1
|
Jensen RT, Niederle B, Mitry E, et al;
Frascati Consensus Conference; European Neuroendocrine Tumor
Society. Gastrinoma (duodenal and pancreatic). Neuroendocrinology.
84:173–182. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Pachera S, Yokoyama Y, Nishio H, et al: A
rare surgical case of multiple liver resections for recurrent liver
metastases from pancreatic gastrinoma: liver and vena cava
resection. J Hepatobiliary Pancreat Surg. 16:692–698. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yamaguchi M, Yamada Y, Hosokawa Y, et al:
Long-term suppressive effect of octreotide on progression of
metastatic gastrinoma with multiple endocrine neoplasia type 1:
seven-year follow up. Intern Med. 49:1557–1563. 2010.PubMed/NCBI
|
|
4
|
Roy PK, Venzon DJ, Shojamanesh H, et al:
Zollinger-Ellison syndrome. Clinical presentation in 261 patients.
Medicine (Baltimore). 79:379–411. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bosman FT, Cameiro F, Hruban RH and Theise
ND: WHO Classification of Tumors of the Digestive system. 4th
edition. IARC Press; Lyon: 2010
|
|
6
|
Kosmahl M, Pauser U, Peters K, Sipos B,
Lüttges J, Kremer B and Klöppel G: Cystic neoplasms of the pancreas
and tumor-like lesions with cystic features: a review of 418 cases
and a classification proposal. Virchows Arch. 445:168–178. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Liu BA, Li ZM, Su ZS and She XL:
Pathological differential diagnosis of solid-pseudopapillary
neoplasm and endocrine tumors of the pancreas. World J
Gastroenterol. 16:1025–1030. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Tanaka Y, Kato K, Notohara K, et al:
Frequent beta-catenin mutation and cytoplasmic/nuclear accumulation
in pancreatic solid-pseudopapillary neoplasm. Cancer Res.
61:8401–8404. 2001.PubMed/NCBI
|
|
9
|
Kim MJ, Jang SJ and Yu E: Loss of
E-cadherin and cytoplasmic-nuclear expression of beta-catenin are
the most useful immunoprofiles in the diagnosis of
solid-pseudopapillary neoplasm of the pancreas. Hum Pathol.
39:251–258. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Abraham SC, Klimstra DS, Wilentz RE, et
al: Solid-pseudopapillary tumors of the pancreas are genetically
distinct from pancreatic ductal adenocarcinomas and almost always
harbor beta-catenin mutations. Am J Pathol. 160:1361–1369. 2002.
View Article : Google Scholar
|
|
11
|
Tanaka Y, Notohara K, Kato K, et al:
Usefulness of beta-catenin immunostaining for the differential
diagnosis of solid-pseudopapillary neoplasm of the pancreas. Am J
Surg Pathol. 26:818–820. 2002. View Article : Google Scholar : PubMed/NCBI
|
